Last update:
Medications news
Medications
Experimental drug BNC210 shows early benefits in PTSD trial
Bionomics Limited is reporting that their experimental drug BNC210, a novel α7 nicotinic acetylcholine receptor modulator, significantly reduced symptom severity in patients with post-traumatic stress disorder (PTSD).
4 hours ago
0
24
Medications
Investigation raises new concerns over landmark trial for top selling anti-platelet drug
An investigation published in The BMJ raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the US and Brilique in Europe), ...
3 hours ago
0
4
Research reveals marijuana hinders Adderall's effects in mice
Adderall is prescribed for attention deficit disorders as a way to help focus.
6 hours ago
0
0
People with inflammatory arthritis currently taking gabapentinoids are more likely to suffer bone fractures
New research led by Keele University and published in the journal BMC Medicine has shown that people with inflammatory arthritis currently using gabapentinoids are more likely to break their bones.
6 hours ago
0
0
Paracetamol may not be as safe as perceived in older people, according to a new study
Research, led by experts at the University of Nottingham, has found that repeated doses of paracetamol in people aged 65 and over, can lead to an increased risk of gastrointestinal, cardiovascular and renal complications.
3 hours ago
0
0
A new class of antivirals could help prevent future pandemics
The arrival of Paxlovid in December 2021 marked another turning point in the COVID-19 pandemic—an effective antiviral that has since successfully treated millions. But like many antivirals before it, scientists know that ...
23 hours ago
0
80
Sepsis trial finds better biomarker guidance reduces antibiotic use
The ADAPT-Sepsis research group has demonstrated that using procalcitonin (PCT) as a biomarker to guide antibiotic duration in critically ill adults with suspected sepsis can significantly reduce treatment length without ...
Human beta cell regeneration research moves closer to a cure for diabetes
Diabetes researchers and bioinformaticians from the Icahn School of Medicine at Mount Sinai have developed a new understanding of how human beta cell regenerative drugs work. These drugs, developed at Mount Sinai, may hold ...
Dec 11, 2024
0
39
Interim analysis: Tecovirimat is safe but does not improve mpox resolution or pain
The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild to moderate clade II mpox and a low risk of developing severe disease, according to an interim data ...
Dec 11, 2024
0
0
Empagliflozin linked to reduced progression of diabetic retinopathy
An investigation led by Brigham and Women's Hospital finds empagliflozin (sold as Jardiance) may reduce the risk of diabetic retinopathy (DR) progression in patients with a history of nonproliferative diabetic retinopathy ...
Exploring opioid-free pain relief in bariatric surgery
Obese patients undergoing bariatric surgery can manage without opioids, according to a thesis from the University of Gothenburg. The research is paving the way for opioid-free treatment during and after surgery.
Dec 10, 2024
0
0
GLP-1 meds may lower clot risk in people with diabetes
People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their odds for a dangerous blood clot, new research finds.
Dec 10, 2024
0
0
Drop in opioid use in Australia offset by spike in private scripts
Australia's use of prescription opioid analgesics, such as oxycodone, morphine, or tramadol, dropped by 21% between 2015 and 2022, despite a substantial increase in private scripts in the same period, according to new research ...
Dec 10, 2024
0
1
Repurposed drug has promising efficacy in non-small cell lung cancer
An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer (NSCLC) with KRAS mutations, a clinical trial led by UT Southwestern Harold C. Simmons Comprehensive Cancer ...
Dec 9, 2024
0
0
Who gets obesity drugs covered by insurance? In North Carolina, it helps if you're on Medicaid
After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets don't work.
Dec 9, 2024
0
0
New method of drug discovery and development offers better understanding of how drugs work
According to a new study published in Nature Communications, researchers at the Department of Laboratory Medicine, Karolinska Institutet, have made a significant leap in drug discovery and development with a new method called ...
Dec 6, 2024
0
0
Chronic kidney disease: Challenges in medication safety
One in ten adults suffer from chronic kidney disease (CKD), a condition characterized by progressive loss of kidney function. Altered kidney function can impact the risk/benefit of many medications. People with advanced chronic ...
Dec 6, 2024
0
0
CDC finds 4′-fluorouridine effectively combats lethal arenavirus infections in guinea pigs
Centers for Disease Control and Prevention-led research demonstrates that an oral antiviral drug, 4′-fluorouridine (4′-FlU), effectively inhibits lethal arenavirus infections in animal models.
Researchers develop new saliva test to rapidly identify paracetamol overdose
A research team led by the University of Liverpool has developed an innovative new technique that can rapidly assess paracetamol levels from saliva.
Dec 5, 2024
0
0
Researchers developing method to make crucial HIV meds easier for children to swallow
Researchers are attempting to improve the uptake of lifesaving HIV medication for infants and children by masking the traditionally bitter taste of the drugs.
Dec 5, 2024
0
0
Clinical trial suggests new drug candidate for spinocerebellar ataxia may offer certain therapeutic benefits
A team has conducted a trial on the efficacy and safety of L-arginine in treating spinocerebellar ataxia type 6 (SCA6).
Dec 4, 2024
0
0
Zepbound bests Wegovy for weight loss in new trial
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.
Dec 4, 2024
0
1
Mexican American women less likely to take stroke prevention medications as prescribed: Study
Women who have had a stroke may be less likely than men to take medications to prevent a second stroke, with Mexican American women reporting the highest rates of nonadherence, according to research published in the Journal ...
Dec 4, 2024
0
0
Promising combo-drug treatment targets melioidosis while leaving gut microbiome bacteria unscathed
Melioidosis—a bacterial infection that causes fever, pneumonia, and sepsis—presents two enormous challenges for infectious disease experts: It kills roughly half the people who contract it and it is extremely tough to ...
Dec 3, 2024
0
12
Study shows text messages can be ineffective as medication refill reminders
A study published in JAMA reveals text message reminders for patients who delay refilling their medications didn't help improve how regularly they refilled medications over a year.
Dec 3, 2024
0
0
